LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) › Shareholders' EquityLIFECORE BIOMEDICAL, INC. \DE\ (LFCR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: $136.06M2012: $149.74M2013: $178.69M2014: $203.07M2015: $218.43M2016: $210.73M2017: $226.61M2018: $252.56M2019: $270.14M2020: $208.00M2021: $155.42M2022: $71.14M2023: -$4.23M2024: $11.31M2025: -$14.20M-$14.20M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$14.20M-225.5%2024$11.31M+367.5%2023-$4.23M-105.9%2022$71.14M-54.2%2021$155.42M-25.3%2020$208.00M-23.0%2019$270.14M+7.0%2018$252.56M+11.5%2017$226.61M+7.5%2016$210.73M-3.5%2015$218.43M+7.6%2014$203.07M+13.6%2013$178.69M+19.3%2012$149.74M+10.1%2011$136.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share